Skip to main content
SpringerLink
Log in

Treatment Guidelines

  • Chapter
  • First Online:
Helicobacter pylori

  • 1909 Accesses

Abstract

Peptic ulcer disease and gastric mucosa-associated lymphoid tissue (MALT) lymphoma are classical indications for Helicobacter pylori (H. pylori) eradication treatment, which is recommended after early gastric cancer resection to prevent its recurrence. There is as yet no consensus about the prophylactic eradication treatment in case of chronic atrophic gastritis, functional dyspepsia, and family history of gastric cancer, and guidelines of different countries represent different views. The scope of indications for eradication treatment has been expanded. In Japan, for example, H. pylori-related gastritis has been added as indication for eradication treatment in an attempt to reduce the risks for H. pylori-related gastric cancer to the maximum possible extent. In the treatment of H. pylori infection, no firm countermeasures against decreasing eradication rate of standard triple therapy have yet been presented. Continuous research is thus necessary to develop improved alternative therapies and reestablishing corresponding therapy guidelines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. J Gastroenterol Hepatol. 2014;29:1371–86.

    Article  PubMed  Google Scholar 

  2. Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer. 2013;132:1272–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD, et al. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis. 2013;14:211–21.

    Article  CAS  PubMed  Google Scholar 

  4. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence consensus report. Gut. 2012;61:646–64.

    Article  CAS  PubMed  Google Scholar 

  5. Korean H. pylori Study Group. Diagnosis and treatment of Helicobacter pylori infection in Korea. Korean J Gastroenterol. 1998;32:275–89.

    Google Scholar 

  6. Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS. Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea. Korean J Gastroenterol. 2009;54:269–78.

    Article  PubMed  Google Scholar 

  7. Lee JY, Kim N. Future trends of Helicobacter pylori eradication therapy in Korea. Korean J Gastroenterol. 2014;63:158–70.

    Article  PubMed  Google Scholar 

  8. Lee JY, Kim N, Kim MS, Choi YJ, Lee JW, Yoon H, et al. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. Dig Dis Sci. 2014;59:1235–43.

    Article  CAS  PubMed  Google Scholar 

  9. Gong EJ, Yun SC, Jung HY, Lim H, Choi KS, Ahn JY, et al. Meta-analysis of first-line triple therapy for Helicobacter pylori eradication in Korea: is it time to change? J Korean Med Sci. 2014;29:704–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lee SY. New guidelines for Helicobacter pylori treatment: comparisons between Korea and Japan. Korean J Gastroenterol. 2014;63:151–7.

    Article  PubMed  Google Scholar 

  11. Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009;44:365–71.

    Article  PubMed  Google Scholar 

  12. Kodama M, Murakami K, Okimoto T, Abe T, Nakagawa Y, Mizukami K, et al. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation. Digestion. 2012;85:126–30.

    Article  PubMed  Google Scholar 

  13. Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol. 2012;47:394–403.

    Article  PubMed  Google Scholar 

  14. Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter. 2010;15:486–90.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–67.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Asaka M, Kato M, Graham DY. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med. 2010;49:633–6.

    Article  PubMed  Google Scholar 

  17. Lee SY. Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea. World J Gastroenterol. 2014;20:1493–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Horiki N, Omata F, Uemura M, Suzuki S, Ishii N, Iizuka Y, et al. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter. 2009;14:86–90.

    Article  CAS  PubMed  Google Scholar 

  19. Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. J Gastroenterol. 2004;39:927–30.

    Article  CAS  PubMed  Google Scholar 

  20. Ji F, Wang ZW, Ning JW, Wang QY, Chen JY, Li YM. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World J Gastroenterol. 2006;12:1770–3.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion. 2011;83:253–60.

    Article  PubMed  Google Scholar 

  22. Sun QJ, Liang X, Zheng Q, Gu WQ, Liu WZ, Xiao SD, et al. Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World J Gastroenterol. 2010;16:5118–21.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Su P, Li Y, Li H, Zhang J, Lin L, Wang Q, et al. Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China. Helicobacter. 2013;18:274–9.

    Article  PubMed  Google Scholar 

  24. Cai W, Zhou L, Ren W, Deng L, Yu M. Variables influencing outcome of Helicobacter pylori eradication therapy in South China. Helicobacter. 2009;14:91–6.

    Article  PubMed  Google Scholar 

  25. Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut. 2007;56:772–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu, 41931, South Korea

    Ju Yup Lee MD

Authors
  1. Ju Yup Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ju Yup Lee MD .

Editor information

Editors and Affiliations

  1. Seoul National University, Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea (Republic of)

    Nayoung Kim

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Lee, J.Y. (2016). Treatment Guidelines. In: Kim, N. (eds) Helicobacter pylori. Springer, Singapore. https://doi.org/10.1007/978-981-287-706-2_48

Download citation

  • DOI: https://doi.org/10.1007/978-981-287-706-2_48

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-287-705-5

  • Online ISBN: 978-981-287-706-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation